Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.

Graff-Guerrero A, Rajji TK, Mulsant BH, Nakajima S, Caravaggio F, Suzuki T, Uchida H, Gerretsen P, Mar W, Pollock BG, Mamo DC.

JAMA Psychiatry. 2015 Sep;72(9):927-34. doi: 10.1001/jamapsychiatry.2015.0891.

PMID:
26131622
2.

Therapeutic window for striatal dopamine D(2/3) receptor occupancy in older patients with schizophrenia: a pilot PET study.

Uchida H, Suzuki T, Graff-Guerrero A, Mulsant BH, Pollock BG, Arenovich T, Rajji TK, Mamo DC.

Am J Geriatr Psychiatry. 2014 Oct;22(10):1007-16. doi: 10.1016/j.jagp.2013.01.045. Epub 2013 Feb 6.

PMID:
25217025
4.

Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.

Ito H, Takano H, Arakawa R, Takahashi H, Kodaka F, Takahata K, Nogami T, Suzuki M, Suhara T.

PLoS One. 2012;7(9):e46488. doi: 10.1371/journal.pone.0046488. Epub 2012 Sep 28.

5.

Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.

Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M.

Arch Gen Psychiatry. 2010 Mar;67(3):231-9. doi: 10.1001/archgenpsychiatry.2010.10.

PMID:
20194823
6.

Effects of the antipsychotic risperidone on dopamine synthesis in human brain measured by positron emission tomography with L-[beta-11C]DOPA: a stabilizing effect for dopaminergic neurotransmission?

Ito H, Takano H, Takahashi H, Arakawa R, Miyoshi M, Kodaka F, Okumura M, Otsuka T, Suhara T.

J Neurosci. 2009 Oct 28;29(43):13730-4. doi: 10.1523/JNEUROSCI.4172-09.2009.

7.

The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.

Graff-Guerrero A, Mamo D, Shammi CM, Mizrahi R, Marcon H, Barsoum P, Rusjan P, Houle S, Wilson AA, Kapur S.

Arch Gen Psychiatry. 2009 Jun;66(6):606-15. doi: 10.1001/archgenpsychiatry.2009.43.

PMID:
19487625
8.

Loss of asymmetry in D2 receptors of putamen in unaffected family members at increased genetic risk for schizophrenia.

Lee KJ, Lee JS, Kim SJ, Correll CU, Wee H, Yoo SY, Jeong JM, Lee DS, Lee SI, Kwon JS.

Acta Psychiatr Scand. 2008 Sep;118(3):200-8. doi: 10.1111/j.1600-0447.2008.01223.x.

PMID:
18699953
9.

Dose-finding study of paliperidone ER based on striatal and extrastriatal dopamine D2 receptor occupancy in patients with schizophrenia.

Arakawa R, Ito H, Takano A, Takahashi H, Morimoto T, Sassa T, Ohta K, Kato M, Okubo Y, Suhara T.

Psychopharmacology (Berl). 2008 Apr;197(2):229-35. Epub 2007 Dec 6.

PMID:
18058087
10.

Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.

Mamo D, Graff A, Mizrahi R, Shammi CM, Romeyer F, Kapur S.

Am J Psychiatry. 2007 Sep;164(9):1411-7.

PMID:
17728427
11.

Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men.

Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M, Benkelfat C.

Arch Gen Psychiatry. 2006 Dec;63(12):1386-95.

PMID:
17146013
12.

Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.

Talvik M, Nordström AL, Okubo Y, Olsson H, Borg J, Halldin C, Farde L.

Psychiatry Res. 2006 Dec 1;148(2-3):165-73. Epub 2006 Nov 13.

PMID:
17095199
13.

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia.

Agid O, Mamo D, Ginovart N, Vitcu I, Wilson AA, Zipursky RB, Kapur S.

Neuropsychopharmacology. 2007 Jun;32(6):1209-15. Epub 2006 Nov 1.

14.

Increased caudate dopamine D2 receptor availability as a genetic marker for schizophrenia.

Hirvonen J, van Erp TG, Huttunen J, Aalto S, Någren K, Huttunen M, Lönnqvist J, Kaprio J, Hietala J, Cannon TD.

Arch Gen Psychiatry. 2005 Apr;62(4):371-8.

PMID:
15809404
15.
16.

Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.

Strafella AP, Paus T, Fraraccio M, Dagher A.

Brain. 2003 Dec;126(Pt 12):2609-15. Epub 2003 Aug 22.

PMID:
12937078
17.
18.

A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects.

Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, C Psych, Papatheodorou G, Zipursky RB.

Neuropsychopharmacology. 2001 Aug;25(2):213-23.

19.

Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.

Okauchi T, Suhara T, Maeda J, Kawabe K, Obayashi S, Suzuki K.

Synapse. 2001 Aug;41(2):87-95.

PMID:
11400175
20.

Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.

Hillefors M, von Euler G.

Neurochem Int. 2001 Jan;38(1):31-42.

PMID:
10913686

Supplemental Content

Loading ...
Support Center